Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.

NCT04910438 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-02-16

No results posted yet for this study

Summary

The DepIST-H study, funded by the French AIDS and Hepatitis Research Agency (ANRS), is to estimate prevalence (the number of cases over a given period of time) and incidence (the number of new cases over a given period of time) of anal lesions (condylomas, dysplasia, cancers) by HIV status among MSM in Lomé, Togo

Conditions

  • Papillomavirus Infections
  • HIV Infections

Interventions

OTHER

STIs screening and care

* Screening for anal dysplasia, HPV infection, HIV infection and several STIs (Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, HSV-2 and HBV). * Offering comprehensive care including prevention strategies adapted to the various STIs mentioned above and their complications, particularly the progression to anal cancer for HPV infections in MSM.

Sponsors & Collaborators

  • Université de Lomé, Département de Santé Publique, Lomé, Togo

    collaborator UNKNOWN
  • Bichat Hospital

    collaborator OTHER
  • Espoir Vie-Togo - ONG

    collaborator OTHER
  • Centre Africain de Recherche en Epidémiologie et en Santé Publique, Lomé, Togo

    collaborator UNKNOWN
  • Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire

    collaborator OTHER
  • Laboratoire de Biologie Moléculaire et d'Immunologie, Lomé, Togo

    collaborator UNKNOWN
  • Saint-Louis Hospital, Paris, France

    collaborator OTHER
  • University Hospital, Bordeaux

    collaborator OTHER
  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Charlotte Charpentier · Hôpital Bichat Claude Bernard, Paris, France

  • Didier Ekouevi · Lomé University, Togo

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Togo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04910438 on ClinicalTrials.gov